A high-tech pharmaceutical CRO delivering full-process drug development — from drug discovery and generics to ANDA/BE, SR/CR formulations, nano-delivery, lipid emulsions, and TCM modernization. 164+ patents. 100+ clients served.
Xi'an Taikomed Pharmatech Co., Ltd. is a high-tech enterprise specializing in drug research and development, technology transfer, technical consulting, and technical services. Our core business spans drug discovery, API development, pharmaceutical research, clinical trials, generic drug ANDA/BE services, hospital preparation R&D, and drug registration.
For over a decade, we have been committed to drug R&D excellence, striving to become a leading pharmaceutical research institution and professional drug service provider in China. Leveraging advanced technologies including nano-delivery systems, sustained/controlled release, and reverse engineering, we have successfully developed and registered over 200 drugs — covering chemical generics, TCM preparations, and health products — for more than 100 pharmaceutical enterprises.
Our expertise spans oncology, cardiovascular, gastrointestinal, immunocompromised conditions, and neurological diseases. With 164 invention patents filed, 12 PCT patents, 13 granted domestic patents, 130+ national journal publications, and 11 SCI papers, we invest over 80% of annual revenue in R&D.
Selected drug R&D programs showcasing our technical capabilities across diverse therapeutic areas and formulation technologies.
New chemical entities (NCE) and modified new drugs (Class 2.2) — from target validation through IND-enabling studies, leveraging our synthesis and analysis platforms.
View Projects →Full-process generic drug development: RLD characterization, reverse engineering, formulation optimization, BE study design, and CTD dossier submission. 200+ drugs registered.
View Projects →API process development, impurity profiling, quality control, and pharmaceutical excipient characterization. Supporting drug master file (DMF) filings.
View Projects →Classical prescriptions, TCM compound formulations, hospital preparations, and health food development with Blue Hat certification support.
View Projects →BA/BE clinical trial management, protocol design, site selection, and statistical analysis — ensuring regulatory compliance and data integrity.
View Projects →Registration strategy, CTD/eCTD dossier preparation, CDE query response, and post-approval lifecycle management for NMPA and international markets.
View Projects →From sustained-release generics to cutting-edge nano-delivery, our integrated platforms cover the full spectrum of modern pharmaceutical development.
Osmotic pump, matrix, multi-particulate, and gastro-retentive systems. Full ANDA/BE support with IVIVC modeling and QTPP-driven development. 20+ generic SR/CR formulations delivered.
Learn More →Liposomes, nanoparticles, lipid emulsions, and microemulsion platforms. From preformulation through scale-up — a complete nano-formulation CRO solution.
Learn More →20+ parenteral nutrition and drug-loaded emulsion formulations. High-pressure homogenization, multi-chamber bag technology, and SMOF/structured lipid expertise.
Learn More →Classical prescriptions, compound formulations, formula granules, hospital preparations, and TCM secondary development. Fingerprint-based quality control and mechanism-of-action research.
Learn More →Synthetic biology, chiral compound process development, structural modification, GTI process control, and impurity profiling. 60+ industrialized mature processes with kg-scale capability.
Learn More →API quality studies, solid dosage (SR/CR) quality research, GTI method development & validation, and elemental impurity analysis per ICH Q3D. LC-MS/MS, GC-MS/MS, ICP-MS platforms.
Learn More →From molecule to market — a seamless, integrated CRO service chain covering every stage of drug development.
End-to-end generic drug development: RLD characterization, preformulation, reverse engineering, dissolution profile comparison (f2), BE study design, and CTD dossier preparation.
Learn More →In-hospital pharmaceutical preparation development including TCM hospital preparations, formulation screening, quality standards, stability studies, and filing & registration support.
Learn More →Health food (Blue Hat certification), disinfection products, and topical products. Formula design, functional validation, stability testing, and regulatory registration & filing.
Learn More →National Healthcare Security Administration released the 2026 NRDL adjustment work plan — 10-day application window, commercial insurance dual-channel, and yellow/red label early warning system.
Students and faculty from the School of Ecological Environment and Chemical Engineering visited Taikomed to deepen university-enterprise cooperation and expand graduate employment channels.
Reflecting on 2025 achievements and charting the course for 2026, Taikomed's management reaffirms commitment to pharmaceutical innovation and client success.
Partner with a CRO that combines technical depth, regulatory expertise, and 15 years of proven delivery. Let's discuss your next project.
Contact Our Team →